Becomes first company to showcase four routes of synthesis for approved siRNA therapeutic asset——Joint poster with Bachem demonstrates ...
A compound found in a parasitic fungus that commonly paralyzes and kills caterpillars has been shown to block pathways ...
Positive 270-day Interim Clinical Study Data for the First Subject and Positive 180-day Interim Clinical Study Data for the Second Subject Treated with the Low-Dose of BB-301 in the Phase 1b/2a ...
Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review ...